Polymerase chain reaction (PCR) and in situ hybridization (ISH) have revolutionized the study of genes and gene expression, and many of these molecular biology advances will greatly impact research in toxicological pathology. PCR is one of the most powerful tools in molecular biology and involves primer-mediated enzymatic in vitro amplification of specific target DNA sequences. Recent innovative methods utilizing PCR technology have been developed to detect mutations in neoplastic and small subpopulations of cells, to study biomarkers of genetic susceptibility and genes involved with carcinogen metabolism, to estimate mutation frequencies, to find novel genes induced by chemical exposure, and to characterize gene expression. ISH provides data on individual cells rather than an average of total cellular populations and allows analysis for heterogeneity. When combined with PCR. the sensitivity of ISH is elevated, and single-copy DNA sequences, single-base mutations, or low copies of messenger RNA (mRNA) can potentially be detected within individual cells. Herein are reviewed ISH- and PCR-based techniques such as single-strand conformation polymorphism analysis to detect point mutations, allelotypic analysis for loss of heterozygosity, differential display of mRNA to characterize gene expression, quantitative reverse transcriptase polymerase chain reaction, and in situ polymerase chain reaction with emphasis on current or potential applications in toxicological pathology. These new and evolving techniques offer tremendous potential in providing new insights into the molecular basis of toxicity and carcinogenesis.
Aguilar F. and Cerutti P. (1994). Genotypic mutation analysis by RFLP/PCR. In: Methods in Toxicology, CA Tyson and JM Frazier (eds). Academic Press. San Diego. pp. 237-247.
2.
Alison M., Chaudry Z., Baker J., and Lauder I. (1994). Liver regeneration : A comparison of in situ hybridization for histone mRNA with bromodeoxyuridine labeling for the detection of S-phase cells. J. Histochem. Cytochem. 42: 1603-1608.
3.
Bagasra O., Seshamma T., Hansen J., Bobroski L., Saikumari P., Pestaner JP, and Pomerantz RJ (1994). Application of in situ PCR methods in molecular biology: I. Details of methodology for general use. Cell Vision1: 324-335.
4.
Bagasra O., Seshamma T., and Pomerantz RJ (1993). Polymerase chain reaction in situ: Intracellular amplification and detection of HIV-1 proviral DNA and other specific genes . J. Immunol. Methods158: 131-145.
5.
Ballhausen WG and Kraus C. (1993). Non-isotopic detection of single-stranded conformation polymorphisms using ethidium bromide/UV light . Appl. Theor. Electrophor. 3: 129-131.
6.
Baskin DG and Stahl WL (1993). Fundamentals of quantitative autoradiography by computer densitometry for in situ hybridization with emphasis on 33P. J. Histochem. Cytochem. 41: 1767-1776.
7.
Bauer D., Muller H., Reich J., Riedel H., Ahrenkiel V., Warthoe P., and Strauss M. (1993). Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res. 21: 4272-4280.
8.
Bauer-Hofmann R., Buchmann A., Mahr J., Kress S., and Schwarz M. (1992). The tumor promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice. Carcinogenesis13: 477-481.
9.
Bauer-Hofmann R., Klimek F., Buchmann A., Muller O., Bannasch P., and Schwarz M. (1992). Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H/He mice. Mol. Carcin. 6: 60-67.
10.
Bej AK, Mahbubani MH, and Atlas RM (1991). Amplification of nucleic acids by polymerase chain reaction (PCR) and other methods and their applications. Crit. Rev. Biochem. Mol. Biol. 26: 301-334.
11.
Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J., Brubaker LH, Kadlubar FF, and Lucier GW (1993). Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis14: 1689-1692.
12.
Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, and Lucier GW (1993). Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85: 1159-1164.
13.
Bibbo M., Pestaner JP, Scavo LM, Bobroski L., Seshamma T., and Bagasra O. (1994). Surfactant protein A mRNA expression utilizing the reverse transcription in situ PCR for metastatic adenocarcinoma. Cell Vision1: 290-293.
14.
Breneman JW , Ramsey MJ, Lee DA, Eveleth GG, Minkler JD, and Tucker JD (1993). The development of chromosome-specific composite DNA probes for the mouse and their application to chromosome painting . Chromosoma102: 591-598.
15.
Canzian F., Ushijima T., Serikawa T., Wakabayashi K., Sugimura T., and Nagao M. (1994). Instability of microsatellites in rat colon tumors induced by heterocyclic amines. Cancer Res. 54: 6315-6317.
16.
Celeda D., Bettag U., and Cremer C. (1992). A simplified combination of DNA probe preparation and fluorescence in situ hybridization. Z. Naturforsh. 47C: 739-747.
17.
Cerutti P., Hussain P., Pourzand C., and Aguilar F. (1994). Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene. Cancer Res.54: 1934s-1938s.
18.
Cha RS, Zarbl H., Keohavong P., and Thilly WG (1992). Mismatch amplification mutation assay (MAMA): Application to the c-H-ras gene. PCR Methods Appl. 2: 14-20.
19.
Chen J. and Viola MV (1991). A method to detect ras point mutations in small subpopulations of cells. Anal. Biochem. 195 : 51-56.
20.
Chiocca SM, Sandy MS, and Cerutti PA (1992). Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by Taq-I restriction fragment length polymorphismlpolymerase chain reaction in the c-H-ras1 gene. Proc. Natl. Acad. Sci. 89: 5331-5335.
21.
Chou MY, Chang ALC, McBride J.Donoff B., Gallagher GT and Wong DTW (1990). A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am. J. Pathol. 136: 729-733.
22.
Cortopassi GA and Arnheim N. (1992). Using the polymerase chain reaction to estimate mutation frequencies and rates in human cells. Mut. Res. 277: 239-249.
23.
Cotter FE (1994). The role of polymerase chain reaction in pathology . J. Histotechnol. 17: 253-259.
24.
Davis LM, Caspary WJ, Sakallah SA, Maronpot RR, Wiseman R., Barrett JC, Elliot R., and Hozier JC (1994). Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis15: 1637-1645.
25.
DeLellis RA (1994). In situ hybridization techniques for the analysis of gene expression: Applications in tumor pathology . Hum. Pathol. 25: 580-585.
26.
Douglass J. , McKinzie AA, and Couceyro P. (1995). PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15: 2471-2481.
27.
Ebina M., Martinez A., Birrer MJ, and Linnoila RI (1995). Topographic mapping of p53 mutations in non-small cell lung cancer: Novel approach to carcinogenesis using in situ PCR. Proc. 86th Ann. Meet. Am. Assoc. Cancer Res., Toronto , Canada. 36: 578 (Abstract 3443).
28.
Erlich HA (1989). PCR Technology: Principles and Applications for DNA Amplification. Stockton Press, New York.
29.
Felley-Bosco E., Pourzand C., Zijlstra J., Amstad P., and Cerutti P. (1991). A genotypic mutation system measuring mutations in restriction recognition sequences. Nucleic Acids Res. 19: 2913-2918.
30.
Finckh U., Lingenfelter PA, and Meyerson D. (1991). Producing single-stranded DNA probes with the Taq DNA polymerase: A high yield protocol. Biotechniques10: 35-38.
31.
Foley KP, Leonard MW, and Engel JD (1993). Quantitation of RNA using the polymerase chain reaction. Trends Genet. 9: 380-385.
32.
Gall JG and Pardue ML (1969). Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc. Natl. Acad. Sci. 63: 378-382.
33.
Gilliland G. , Perrin S., and Bunn HF (1990). Competitive PCR for quantitation of mRNA. In: PCR Protocols: A Guide to Methods and Applications , M Innis, D Gelfand, J Sninsky, and T White (eds). Academic Press, San Diego , pp. 60-69.
34.
Goodrow TL, Prahalada SR, Storer RD, Manam SV, Leander KR, Kraynak AR, van Zwieten MJ, Nichols WW, and Bradley MO (1992). Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids. Lab. Invest. 66: 504-511.
35.
Grade K., Grunewald I., Graupner I., Behrens F., and Coutelle C. (1994). Identification of three novel mutations in the CFTR gene using temperature-optimized non-radioactive conditions for SSCP analysis. Human Genetics94: 154-158.
36.
Griffin HG and Griffin AM (1994). PCR Technology: Current Innovations. CRC Press, Boca Raton, Florida.
37.
Grompe M. (1993). The rapid detection of unknown mutations in nucleic acids. Nature Genet. 5 : 111-117.
38.
Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, and Wiseman RW (1994). Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res . 54: 6257-6264.
39.
Heniford BWShum-Siu A., Leonberger M., and Hendler FJ (1993). Variation in cellular EGF receptor mRNA expression demonstrated by in situ reverse transcriptase polymerase chain reaction. Nucleic Acids Res. 21: 3159-3166.
40.
Herrington CS and McGee JO (1992). Principles and basic methodology of DNA/RNA detection by in situ hybridization. In: Diagnostic Molecular Pathology . CS Herrington and JO McGee (eds). Oxford University Press. New York, pp. 69-102.
41.
Hongyo T.Buzard GSCalvert RJ and Weghorst CM (1993). "Cold SSCP" A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res. 21: 3637-3642.
42.
Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DCGoodman SN, Kensler TWBose KKCameron JL and Bos JL (1993). K-ras oncogene activation in adenocarcinoma of the human pancreas. Am. J. Pathol. 143: 545-554.
43.
Jacobson DR and Mills NE (1994). A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene9: 553-563.
44.
Kallioniemi A.Kallioniemi O.Sudar D., Rutovitz D., Gray JWWaldman F., and Pinkel D. (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science258: 818-821.
45.
Kallioniemi O., Kallioniemi A., Sudar D.Rutovitz D.Gray JW, Waldman F., and Pinkel D. (1993). Comparative genomic hybridization: A rapid new method for detecting and mapping amplification in tumors. Semin. Cancer Biol. 4: 41-46.
46.
Kemp CJ, Fee F., and Balmain A. (1993). Allelotypic analysis of mouse skin tumors using polymorphic microsatellites: Sequential genetic alterations on chromosome 6,7, and 11. Cancer Res. 53: 6022-6027.
47.
Komminoth P. and Long AA (1993). In-situ polymerase chain reaction. Virchows Archiv. B Cell Pathol. 64: 67-73.
48.
Komminoth P. and Long AA (1994). Correspondence: Questioning in situ PCR. Am. J. Pathol. 145: 742.
49.
Komminoth P. , Long AA, Ray R., and Wolfe HJ (1992). In situ polymerase chain reaction detection of viral DNA, single-copy genes, and gene rearrangements in cell suspensions and cytospins. Diag. Mol. Pathol. 1: 85-97.
50.
Kumar R., Sukumar S., and Barbacid M. (1990). Activation of ras oncogenes preceding the onset of neoplasia. Science248: 1101-1104.
51.
Kwok S. and Higuchi R. (1989). Avoiding false positives with PCR. Nature (London)339: 237-238.
52.
Leong PK, Thorner P., Yeger H.Ng K., Zhang Z., and Squire J. (1993). Detection of MYCN gene amplificatian and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Lab. Invest. 69: 43-50.
53.
Li Z-H. , Zheng J., Weiss LM, and Shibata D. (1994). c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am. J. Pathol . 144: 303-309.
54.
Liang P., Averboukh L., Keyomarsi K., Sager R., and Pardee AB (1992). Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52: 6966-6968.
55.
Liang P.Averboukh L. and Pardee AB (1993). Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimization. Nucleu Aculs als Res21: 3269-3275.
56.
Liang P. and Pardee AB (1992). Differennal display of eucaryotic messenger RNA by means of the poly merase chain reactionScience257: 967-971.
57.
Loda M. (1994). Polvmerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes. Hum. Pathol. 25: 564.-571
58.
Loeb L. (1994). Microsatellite instability Marker of a mutator phenotype in cancer. Cancer Res.545059-5063.
59.
Long AA, Komminoth P.Lee E. and Wolfe HJ (1993). Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Histochemistry99: 151-162.
60.
Manenti G., DeGregorio L., Gariboldi M., Dragani TA and Pierotti MA (1995) Analysis of loss of heterozygosity in munne hepatocellular tumors. Mol. Curcin. 13: 191-200.
61.
Maronpot RR , Fox T., Malarkey DE and Coldsworthy T. (1995). Mutations in the ras proto-oncogene Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology101: 125-156.
62.
McGlynn KARosvoid EALustbader ED, Hu Y., Clapper ML, Zhou T.Wild CP, Xia X.Baffoe-Bonnie A.Ofori-Adjei D., Chen G., London WTShen F., and Buetow KH (1995). Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl. Acad. Sci. USA92: 2384-2387.
63.
Mies C. (1994). Molecular biological analysis of paraffin-embedded tissues. Hum. Pathol. 25: 555-560.
64.
Mills NE, Fishman CL, Rom WN, Dubin N., and Jacobson DR (1995). Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55: 1444-1447.
65.
Montone KT and Brigati DJ (1994). In situ molecular pathology: Instrumentation, oligonucleotides, and viral nucleic acid detection. J. Histotechnol . 17: 195-201.
66.
Moorman AFM , Deboer PAJ, Vermuellen JLM, and Lamers WH (1993). Practical aspects of radioisotopic in situ hybridization on RNA. Histochem. J. 25: 251-266.
67.
Mou L., Miller H., Li J., Wang E., and Chalifour L. (1994). Improvements to the differential display method for gene analysis. Biochem. Biophys. Res. Commun. 199: 564-569.
68.
Moulds BA and Goodman JI (1994). Spontaneous mutation at codon 61 of the Ha-ras gene in the nascent liver of B6C3F1, C3H/ He and C57BL/6 mice. Mut. Res. 311: 1-7.
69.
Muleris M., Almeida A., Gerbault-Seureau M., Malfoy B., and Dutrillaux B. (1994). Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromos. Cancer10: 160-170.
70.
Mullis KB and Faloona FA (1987). Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155: 335-350.
71.
Myers B. and Parry JM (1994). The application of the restriction site mutation assay to the study of the induction of mutations in the tissues of rodents . Mutagenesis9: 175-177.
72.
Nagase H. and Nakamura Y. (1993). Mutations of the APC (adenomatous polyposis coli) gene. Hum. Mutat. 2: 425-434.
73.
Nelson MA, Sanchez IM, Bull RJ, and Sylvester SR (1990). Increased expression of c-myc and c-H-ras in dichloroacetate and trichloroacetate-induced liver tumors in B6C3F1 mice. Toxicology64: 47-57.
74.
Newcomb EW, Bayona W., and Pisharody S. (1995). N-methylnitrosourea-induced Ki-ras codon 12 mutations: Early events in mouse thymic lymphomas. Mol. Carcin. 13: 89-95.
75.
Nuovo GJ (1994). Correspondence: Questioning in situ PCR. Am. J. Pathol. 145: 741.
76.
Nuovo GJ (1994). PCR In Situ Hybridization: Protocols and Applications, 2nd ed. Raven Press, New York.
77.
Nuovo GJ (1994). RT in situ PCR with direct incorporation of digoxigenin-11-dUTP: Protocol and applications. Biochemica11: 4-6.
78.
Nuovo GJ, MacConnell P., Forde A., and Delvenne P. (1991). Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction . Am. J. Pathol. 139: 847-854.
79.
Orita M., Suzuki Y., Sekiya T., and Hayashi K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics5: 874-879.
80.
Papp T., Jafari M., Kopp C., and Schiffmann D. (1992). Aci I and Bst NI/Cfr I detect all possible activating point mutations at codons 13 and 61 of the human H-ras oncogene. Hum. Mol. Genet. 1: 649.
81.
Patel VG, Shum-Siu A., Heniford BW, Wieman TJ, and Hendler FJ (1994). Detection of epidermal growth factor receptor mRNA in tissue sections using in situ polymerase chain reaction. Am. J. Pathol. 144: 7-14.
82.
Richardson KKHelvering IM, Copple DM, Rexroat MA, Linville DWEngelhardt JATodd GC and Richardson FC (1992). Genetic alterations in the 61st codon of the H-ras oncogene isoloated from archival sections of hepatic hyperplasias, adenomas and carcinomas in controls groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986. Carcinogenesis13: 935-941.
83.
Riedy MC, Timm J E.A., and Stewart CC (1995). Quantitative RT-PCR for measuring gene expression . Biotechniques18: 70-76.
84.
Saiki RK, Bugawan TL, Horn GT, Mullis KB, and Ehrlich HA (1986). Analysis of enzymatically amplified B-globin and HLA-DQα-DNA with allele-specific oligonucleotide probes. Nature (London)324: 163-166.
85.
Saiki RK, Gelfand DH, Stoffel S., Scharf SJ, Higuchi R., Horn GT, Mullis KB, and Ehrlich HA (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science239: 487-491.
86.
Sambrook J., Fritsch EF, and Maniatis T. (1989). In vitro amplification of DNA by the polymerase chain reaction. In: Molecular Cloning: A Laboratory Manual , J Sambrook, EF Fritsch, and T Maniatis (ed). Cold Spring Harbor Press, Cold Spring Harbor , New York.
87.
Selmin O., Lucier GW, Clark GC, Tritscher AM, Vanden Heuvel JP, Sutter TR, Gastel JA, and Bell DA (1995). TCDD-induced expression of a novel gene in rat liver. In: Proceedings of 1995 Annual Meeting of the Society of Toxicology, Baltimore, Maryland. The Toxicologist 15: 236 (Abstract 1265).
88.
Sheffield VC , Beck JS, Kwitek AE, Sandstrom DW, and Stone EM (1993). The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions . Genomics16: 325-332.
89.
Shibata D., Hawes D., Li Z-H., Hernandez AM, Spruck CH, and Nichols PW (1992). Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction. Am. J. Pathol. 141: 539-543.
90.
Shibata D., Peinado MA, Ionov Y., Malkhosyan S., and Perucho M. (1994). Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation . Nature Genet. 6: 273-281.
91.
Shinoura N. , Shamraj OI, Hugenholz H., Zhu JG, McBlack P., War-nick R., Tew JJ, Wani MA, and Menon AG (1995). Identification and partial sequence of a cDNA that is differentially expressed in human brain tumors . Cancer Lett. 89: 215-221.
92.
Stanley LA (1995). Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes. Toxicology96: 173-194.
93.
Templeton NS (1992). The polymerase chain reaction: History, methods, and applications. Diag. Mol. Pathol. 1 : 58-72.
94.
Tervahauta AI, Syrjanen SM, Kallio PJ, and Syrjanen KJ (1992). Immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR) in detecting c-myc expression in human malignancies. Anticaner Res. 12: 1005-1012.
95.
Thompson CH and Rose BR (1991). Deleterious effects of formalin/acetic acid/alcohol (FAA) fixation on the detection of HPV DNA by in situ hybridization and the polymerase chain reaction. Pathology23: 327-330.
96.
Vanden Heuvel JP, Clark GC, Kohn MC, Tritscher AM, Greenlee WF, Lucier GW, and Bell DA (1994). Dioxin-responsive genes: Examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54: 62-68.
97.
Vanden Heuvel JP, Clark GC, Thompson CL, McCoy Z., Miller CR, Lucier GW, and Bell DA (1993). CYP1A1 mRNA levels as a human exposure biomarker: Use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes . Carcinogenesis14: 2003-2006.
98.
Vanden Heuvel JP, Tyson FL, and Bell DA (1993). Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques14: 395-398.
99.
Vogel P. and Kell WM (1994). A method for controlling evaporation losses from specimens on glass slides during in situ PCR. Cell Vision1 : 336-338.
100.
Waller HA and Savage AK (1994). Analysis of gene transcription in situ: Methodological considerations and applications in pathology. J. Histotechnol . 17: 203-218.
101.
Wang AM and Mark DF ( 1990). Quantitative PCR. In: PCR Protocols: A Guide to Methods and Applications, M Innis.D Gelfand.J Sninsky, and T White (eds). Academic Press. San Diego. pp. 70-75.
102.
Wang X. and Feuerstein GZ (1994). Direct sequencing of DNA isolated from mRNA differential display. Biotechniques18: 448-452.
103.
White BA (1993). PCR Protocols: Current Methods and Applications . Humana Press, Totowa, New Jersey .
104.
Wiegant J., Mascheretti S., and Raap AK (1995). Renaissance: Use of fluorochrome-labeled dUTPs in fluorescence in situ hybridization (FISH). Dupont Biotech. Update Spring95: 2-5.
105.
Wilcox JN (1993). Fundamental principles of in situ hybridization . J. Histochem. Cytochem. 41: 1725-1733.
106.
Williams JF (1989). Optimization strategies for the polymerase chain reaction. Biotechniques7: 762-768.
107.
Wolman SR (1994). Flourescence in situ hybridization: A new tool for the pathologist. Hum. Parhol. 25: 586-590.
108.
Wu AMBen-Ezra J.Winberg C.Colombero AM and Rappaport H. (1990). Analysis of antigen receptor gene rearrangements in ethanol and formaldehyde-fixed. paraffin embedded specimens. Lab. Invest. 63 : 107-114.
109.
Yakubovskaya MS, Spiegelman VSMalaev S.Belitsky GA and Ronai Z. (1995). Detection of K-ras mutations in sputum of patients with lung cancer using a highly sensitive quantitative enriched PCR (QEPCR). Proc. 86th Ann. Meet, Am. Assoc. Cancer Res.. Toronto, Canada 36: 639 (Abstract 3807).
